ES2129013A1 - Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea. - Google Patents

Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.

Info

Publication number
ES2129013A1
ES2129013A1 ES09750014A ES9750014A ES2129013A1 ES 2129013 A1 ES2129013 A1 ES 2129013A1 ES 09750014 A ES09750014 A ES 09750014A ES 9750014 A ES9750014 A ES 9750014A ES 2129013 A1 ES2129013 A1 ES 2129013A1
Authority
ES
Spain
Prior art keywords
vitamin
derivatives
skin
analogues
elastin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09750014A
Other languages
English (en)
Other versions
ES2129013B1 (es
Inventor
Marc Dumas
Frederic Bonte
Alain Meybeck
Catherine Chaudagne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Publication of ES2129013A1 publication Critical patent/ES2129013A1/es
Application granted granted Critical
Publication of ES2129013B1 publication Critical patent/ES2129013B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilización de la vitamina C o de sus derivados o análogos para estimular la síntesis de la elastina cutánea. La invención se refiere a la utilización del ácido ascórbico particularmente del ácido L-ascórbico o vitamina C, o de su isómero el ácido eritórbico, o de sus sales o esteres, para estimular la síntesis de elastina en la dermis con miras a mejorar en particular la elasticidad cutánea. La invención permite fabricar composiciones cosméticas o farmacéuticas, particularmente dermatológicas, para mejorar la elasticidad cutánea, por ejemplo en el marco de producto que mejora la tonicidad cutánea o reafirmante cutáneo. La invención permite igualmente aumentar el contenido en elastina de dermis artificiales.
ES009750014A 1995-08-25 1997-04-25 Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea. Expired - Fee Related ES2129013B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510093A FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Publications (2)

Publication Number Publication Date
ES2129013A1 true ES2129013A1 (es) 1999-05-16
ES2129013B1 ES2129013B1 (es) 2000-04-01

Family

ID=9482092

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009750014A Expired - Fee Related ES2129013B1 (es) 1995-08-25 1997-04-25 Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.

Country Status (13)

Country Link
US (1) US5801192A (es)
JP (1) JP4313846B2 (es)
AU (1) AU5407796A (es)
BE (1) BE1009858A5 (es)
CA (1) CA2202629A1 (es)
CH (1) CH690489A5 (es)
DE (1) DE19680859T1 (es)
ES (1) ES2129013B1 (es)
FR (1) FR2737971B1 (es)
GB (1) GB2308811B (es)
IT (1) IT1284758B1 (es)
NL (1) NL1003883C2 (es)
WO (1) WO1996019099A2 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768927B1 (fr) * 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
FR2791259B1 (fr) * 1999-03-24 2001-08-17 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogues pour augmenter le taux de differenciation et/ou de proliferation des cellules de la peau
FR2791261A1 (fr) * 1999-03-24 2000-09-29 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogue pour promouvoir la transformation de procollagenes inactifs en collagenes actifs
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
FR2795956B1 (fr) * 1999-07-06 2006-07-14 Inst Evaluation Dermatophysiqu Composition cosmetique pour ameliorer l'elasticite de la peau et lutter contre son vieillissement
WO2001043711A1 (en) * 1999-12-14 2001-06-21 Unilever Plc Cosmetic skin conditioning compositions containing red yeast rice extract
FR2807320B1 (fr) * 2000-04-10 2002-05-24 Oreal Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
FR2807322B1 (fr) * 2000-04-10 2004-02-20 Oreal Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US6468552B1 (en) * 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
WO2003018003A1 (en) * 2001-08-24 2003-03-06 Matthias Rath Ascorbic acid derivatives with essential amino acids, nonessential amino acids that do not occur in protein
HRP20040207A2 (en) * 2001-08-24 2005-02-28 Rath Matthias Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
FR2832630B1 (fr) * 2001-11-28 2005-01-14 Oreal Composition cosmetique et/ou dermatologique contenant au moins un actif hydrophile sensible a l'oxydation stabilise par au moins un copolymere de n-vinylimidazole
KR100505105B1 (ko) * 2001-12-20 2005-07-29 샘즈바이오 주식회사 삼중 코팅구조의 비타민 에이씨(레티닐 팔미테이트와순수비타민 씨) 및 그를 함유하는 화장료 조성물
DE60302389T2 (de) * 2002-06-20 2006-07-13 L'oreal S.A. Kosmetische und/oder dermatologische Verwendung einer Zusammensetzung, die mindestens einen oxidationsempfindlichen hydrophilen Wirkstoff enthält, der mit mindestens einem Copolymer von Maleinsäureanhydrid stabilisiert ist
FR2846005B1 (fr) * 2002-10-16 2006-06-23 Maco Pharma Sa Composition pour milieu biologique comprenant de l'erythorbate de sodium
AU2002353388A1 (en) * 2002-12-20 2004-07-14 Council Of Scientific And Industrial Research Herbal composition for cuts, burns and wounds
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
JP2005247826A (ja) * 2004-02-04 2005-09-15 Kose Corp デコリン産生促進剤及びそれを含有する皮膚外用剤
KR100868905B1 (ko) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물
CN101217999A (zh) * 2005-07-08 2008-07-09 宝洁公司 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2911779B1 (fr) 2007-01-30 2009-04-24 Lvmh Rech Composition contenant un extrait d'ambre
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
JP5679684B2 (ja) * 2010-03-17 2015-03-04 グンゼ株式会社 Ｄａｎｃｅタンパク質含有組織再生用基材
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
US20130089641A1 (en) * 2011-10-11 2013-04-11 Sunway Biotech Co., Ltd. Soymilk with Additive of Vitamin C, Vitamin C salt or Vitamin C Stereoisomer
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
DK3072535T5 (en) * 2015-03-26 2017-06-06 Univ Bordeaux METHOD OF RECONSTRUCTION OF SKIN
ITUB20152183A1 (it) * 2015-07-15 2017-01-15 Germano Laghi Miscela di principi attivi cosmetici per la preparazione di un gel cosmetico e metodo per la preparazione di detto gel
KR102354282B1 (ko) * 2017-05-17 2022-01-21 주식회사 엘지생활건강 에리소르빈산을 포함하는 화장료 조성물
JP2019069912A (ja) * 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物およびその製造方法
EP3866771A4 (en) * 2018-10-18 2022-07-27 Baek Clinical Inc. HIGH DOSAGE TOPICAL VITAMIN C FORMULATIONS
AU2021255734A1 (en) 2020-04-16 2022-11-24 Mf Beauty Partners Llc Stabilizing vitamin C application formulations

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
FR2612775A1 (fr) * 1987-03-25 1988-09-30 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
FR2666226A1 (fr) * 1990-08-30 1992-03-06 Jean Noel Thorel Composition protectrice de la peau.
WO1995025524A1 (fr) * 1994-03-18 1995-09-28 Lvmh Recherche UTILISATION DU GINSENOSIDE Ro OU D'UN EXTRAIT VEGETAL EN CONTENANT POUR STIMULER LA SYNTHESE DU COLLAGENE
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5262635A (en) * 1975-11-20 1977-05-24 Matsushita Electric Industrial Co Ltd Method of producing zinc electrode
EP0282746A1 (en) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Method for producing artificial cultured tissue
EP0537092A1 (fr) * 1991-10-08 1993-04-14 Patrinove Societe Civile Vecteurs vésiculaires infracellulaires et leurs applications dans les compositions cosmétiques, médicamenteuses et les milieux de culture
FR2735982B1 (fr) * 1995-06-27 1997-09-19 Lvmh Rech Composition cosmetique ou pharmaceutique contenant un extrait de plantes du genre filicium

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
FR2612775A1 (fr) * 1987-03-25 1988-09-30 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
FR2666226A1 (fr) * 1990-08-30 1992-03-06 Jean Noel Thorel Composition protectrice de la peau.
WO1995025524A1 (fr) * 1994-03-18 1995-09-28 Lvmh Recherche UTILISATION DU GINSENOSIDE Ro OU D'UN EXTRAIT VEGETAL EN CONTENANT POUR STIMULER LA SYNTHESE DU COLLAGENE
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS HCAPLUS, Chemical Abstracts Service, Columbus, OH, USA, AN 1970:29295, BARNES, M.J.: "Ascorbic acid and the biosynthesis of collagen and elastin", Bibl. "Nutr. Dieta" (1969), no 13, paginas 86-98 *
BASE DE DATOS HCAPLUS, Chemical Abstracts Service, Columbus, OH, USA, AN 1993:66557, HAYASHI, A. et al.: "The mechanism of wrinkle formation and its prevention from a view of the studies of extracellular matrix", Fragrance J., (1992), 20 (11), paginas 43-8 *
BASE DE DATOS PAJ, Japanese Patent Information Organisation, Tokyo, Vol. 12 no 306 & JP 63079809 A (SHISEIDO CO. LTD.) 09.04.1988 *

Also Published As

Publication number Publication date
GB2308811A (en) 1997-07-09
NL1003883C2 (nl) 1997-02-27
AU5407796A (en) 1996-07-10
GB2308811B (en) 2000-04-05
WO1996019099A3 (fr) 1997-04-10
JPH10509735A (ja) 1998-09-22
CA2202629A1 (en) 1996-06-27
BE1009858A5 (fr) 1997-10-07
GB2308811A8 (en) 1999-05-21
US5801192A (en) 1998-09-01
DE19680859T1 (de) 1997-10-02
ITTO960710A1 (it) 1998-02-20
CH690489A5 (fr) 2000-09-29
ES2129013B1 (es) 2000-04-01
GB9708362D0 (en) 1997-06-18
IT1284758B1 (it) 1998-05-21
JP4313846B2 (ja) 2009-08-12
WO1996019099A2 (fr) 1996-06-27
NL1003883A1 (nl) 1997-02-27
FR2737971A1 (fr) 1997-02-28
FR2737971B1 (fr) 1997-11-14

Similar Documents

Publication Publication Date Title
ES2129013A1 (es) Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.
ES2421262T3 (es) Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
ES2003605A6 (es) Procedimiento de obtencion de una composicion farmaceutica particularmente dermatologica o cosmetica a base de fases laminares lipidicas hidratas o de liposomas que contienen un retinoide o un analogo estructural de dicho retinoide tal como un carotenoide.
DE69902131D1 (de) Kosmetische und/oder dermatologische Zusammensetzung enthaltend Salicylsäure oder ihre Derivate und ihre Verwendung
ES2050074A1 (es) Composicion cosmetica para el aclarado de la piel y procedimiento para su obtencion.
CO2022008243A2 (es) Derivados de 3-(5-metoxi-1-oxoisoindolin-2-il)piperidin-2,6-diona y usos de los mismos
ES2000036A4 (es) Producto cosmetico a base de n-hidroxipropilquitosanas, nuevas n-hidroxipropilquitosanas, asi como procedimiento para su fabricacion.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
DE69108256D1 (de) Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
ES2167516T3 (es) Composiciones para el cuidado de la piel que contienen dimetilimidazolidinona y retinol o ester de retinilo.
ES2032865T3 (es) Procedimiento para un tratamiento hidratante de la piel.
DOP2023000261A (es) Derivados de 3–(1–oxoisoindolin–2–il)piperidina–2,6–diona y sus usos médicos
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
UY28209A1 (es) Derivados de aminoácidos con cicloalquilo, procedimiento para su preparación y su uso como medicamentos.
MX2025005597A (es) Compuestos antisenescencia novedosos y composiciones de los mismos
AR003971A1 (es) Utilizacion de al menos un acido dihidroxibenzoico, procedimiento de tratamiento cosmetico mediante una composicion que contiene dicho acido, y unacomposicion cosmetica y/o dermatologica que contiene dicho acido.
ES2193364T3 (es) Utilizacion de un extracto de potencilla erecta en el campo cosmetico y farmaceutico.
AR037766A1 (es) Compuestos triaromaticos analogos de la vitamina d, su utilizacion, composiciones farmaceuticas y cosmeticas que los comprenden y utilizacion cosmetica de dichas composiciones cosmeticas
UA10208A (uk) Дерматологічний косметичний засіб
ES2009714A4 (es) Composicion a base de fases laminares lipidicas hidratadas o de liposomas que contienen tirosina o un derivado de tirosina y composicion cosmetica o farmaceutica, particularmente dermatologica, de actividad pigmentaria, que la incorpora.
ES2168845T3 (es) Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos.
US20210330576A1 (en) Magic Skin Repair Serum
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
BRPI0505988A (pt) formulação cosmética e/ou dermtólogica e uso da mesma
ES2102818T3 (es) Composicion cosmetica o farmaceutica, particularmente dermatologica, que contiene un extracto de vismia.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990516

Kind code of ref document: A1

Effective date: 19990516

FD1A Patent lapsed

Effective date: 20050511